Generated by Meeveem AI
"Worldwide leader in interventional cardiovascular and endovascular innovation for nearly 70 years."
Cordis develops and manufactures interventional cardiovascular and endovascular technologies that enable physicians to treat vascular disease through minimally invasive procedures. From the first guidewire to the first drug-eluting stent, Cordis has pioneered vascular closure systems, drug-eluting balloons, catheter sheaths, and stents for coronary and peripheral interventions. The company serves clinicians and patients across 60+ countries through internal R&D, strategic partnerships via Cordis-X, and targeted acquisitions. Cordis operates global manufacturing and research facilities, supporting better clinical outcomes through physician education, customer service, and evidence-based development rooted in nearly 70 years of innovation.
2900
Team Members
1957
Founded
Medical Devices
Sector
Hybrid
Work Environment
A future where cardiovascular disease is addressed through breakthrough minimally invasive technologies accessible to physicians and patients worldwide, transforming outcomes and quality of life.
At Cordis, our mission is to transform cardiovascular care through relentless innovation, better clinical outcomes, customer-centered service, and impactful education.